Nanosphere Raises $26.9M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today announced the closing of its public offering that raised $26.9 million in net proceeds.

The offering, announced last week, was of 12,075,000 shares of its common stock at a price of $2.40 per share, including 1,575,000 shares issued to underwriters' exercise in full of an overallotment option. Piper Jaffray was the sole book-running manager, and Roth Capital Partners was the co-manager of the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.